Document is current
Any future updates will be listed below
-
Authors
Funakoshi, Shunsuke
Fernandes, Ian
Mastikhina, Olya
Wilkinson, Dan
Tran, Thinh
Dhahri, Wahiba
Mazine, Amine
Yang, Donghe
Burnett, Benjamin
Lee, Jeehoon
Protze, Stephanie
Bader, Gary D. https://orcid.org/0000-0003-0185-8861
Nunes, Sara S. https://orcid.org/0000-0003-0906-7204
Laflamme, Michael
Keller, Gordon https://orcid.org/0000-0001-9309-9297
-
Funding
Funding for this research was provided by:
Gouvernement du Canada | Canadian Institutes of Health Research (FDN159937)
BlueRock Therapeutics
- License Information
-
More Information
Article History
Received: 16 June 2020
Accepted: 18 April 2021
First Online: 26 May 2021
Competing interests
: G.M.K. is a scientific co-founder and paid consultant for BlueRock Therapeutics LP, a paid consultant for VistaGen Therapeutics and a board member of Anagenesis Biotechnologies. M.A.L. is founding investigator and paid consultant for BlueRock Therapeutics. S.P. is a paid consultant for BlueRock Therapeutics. All other authors declare no competing interests.
